Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001539497-21-001192
Filing Date
2021-08-10
Accepted
2021-08-10 10:01:46
Documents
67
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q n2583-x13_10q.htm   iXBRL 10-Q 1101877
2 CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS exh_31-1.htm EX-31.1 10285
3 CERTIFICATION PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT OF 2002 exh_32-1.htm EX-32.1 5611
  Complete submission text file 0001539497-21-001192.txt   6212419

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bixt-20210630.xsd EX-101.SCH 70984
5 XBRL CALCULATION FILE bixt-20210630_cal.xml EX-101.CAL 50189
6 XBRL DEFINITION FILE bixt-20210630_def.xml EX-101.DEF 250831
7 XBRL LABEL FILE bixt-20210630_lab.xml EX-101.LAB 462484
8 XBRL PRESENTATION FILE bixt-20210630_pre.xml EX-101.PRE 348550
9 EXTRACTED XBRL INSTANCE DOCUMENT n2583-x13_10q_htm.xml XML 1025975
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 211158747
SIC: 2834 Pharmaceutical Preparations